Hany Khalil
Overview
Explore the profile of Hany Khalil including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
3810
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Abdelsattar S, Al-Amodi H, Kamel H, Al-Eidan A, Mahfouz M, El Khashab K, et al.
Int J Mol Sci
. 2025 Jan;
26(1.
PMID: 39795937
Cancer cells undergo metabolic rewiring to support rapid proliferation and survival in challenging environments. Glutamine is a preferred resource for cancer metabolism, as it provides both carbon and nitrogen for...
2.
Said W, Khattab A, Hamed S, Abo El-Maaty S, Khalil H
Asian Pac J Cancer Prev
. 2024 Oct;
25(10):3551-3558.
PMID: 39471021
Objectives: Bidens pilosa and Trianthema portulacastrum are noteworthy weeds with a series of bioactive flavonoid constituents, hence, they can be utilized as potential health supplements and readily available sources of...
3.
Shoaib H, Negm A, Abd El-Azim A, Elawdan K, Abd-ElRazik M, Refaai R, et al.
J Mol Histol
. 2024 Oct;
55(6):1225-1238.
PMID: 39352545
Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths and the fifth most common cancer worldwide. Brown algae appeared to be a rich source of efficient and safe...
4.
Dabous E, Alalem M, Awad A, Elawdan K, Tabl A, Elsaka S, et al.
BMC Cancer
. 2024 Sep;
24(1):1091.
PMID: 39227808
Introduction: MicroRNAs (miRNAs) are single RNA molecules that act as global regulators of gene expression in mammalian cells and thus constitute attractive targets in treating cancer. Here we aimed to...
5.
Eisa A, Hanafy S, Khalil H, Elshal M
J Biochem Mol Toxicol
. 2024 Aug;
38(8):e23796.
PMID: 39087923
5-fluorouracil (5-FU) is an inexpensive treatment for colon cancer; however, its efficacy is limited by chemoresistance. This study investigates the combination therapy approach of 5-FU with Sitagliptin (Sita), a diabetic...
6.
Awad A, Dabous E, Alalem M, Alalem N, Nasr M, Elawdan K, et al.
Sci Rep
. 2024 Jun;
14(1):13492.
PMID: 38866875
Liver cancer is one of the most pivotal global health problems, leading hepatocellular carcinoma (HCC) with a significant increase in cases worldwide. The role of non-coding-RNA in cancer proliferation and...
7.
Tadros E, Guirgis A, Elimam H, Habib D, Hanna H, Khalil H
Nat Prod Res
. 2024 May;
:1-7.
PMID: 38795163
In the current work, we aimed to evaluate the protective effects of liquorice and halfa-bar extract against doxorubicin (DOX)-induced nephritic syndrome (NS) in rats. Twenty albino male rats were intraperitoneally...
8.
Perrone G, Giuffrida M, Abu-Zidan F, Kruger V, Livrini M, Petracca G, et al.
World J Emerg Surg
. 2024 Apr;
19(1):14.
PMID: 38627831
Background: Literature suggests colonic resection and primary anastomosis (RPA) instead of Hartmann's procedure (HP) for the treatment of left-sided colonic emergencies. We aim to evaluate the surgical options globally used...
9.
Baudry M, Wang Y, Bi X, Luo Y, Wang Z, Kamal Z, et al.
Pharmacol Res Perspect
. 2024 Mar;
12(2):e1181.
PMID: 38429943
Our laboratory has shown that calpain-2 activation in the brain following acute injury is directly related to neuronal damage and the long-term functional consequences of the injury, while calpain-1 activation...
10.
Khalil H, Nada A, Mahrous H, Hassan A, Rijo P, A Ibrahim I, et al.
Front Immunol
. 2024 Feb;
14:1206990.
PMID: 38322013
Aim: suppression of methylation inhibitors (epigenetic genes) in hepatocarcinogenesis induced by diethylnitrosamine using glycyrrhetinic acid. Method: In the current work, we investigated the effect of sole GA combined with different...